Hyodeoxycholic Acid Ameliorates Metabolic Syndrome Through Pathways of Primary Bile Acid Synthesis and Fatty Acid Degradation: Insights From a Rat Model
These study is the first to highlight HDCA as a therapeutic candidate for MS and provides new insights into the BA-MS axis, though further validation is needed.
Authors
- Meimei Chen (ORCID: https://orcid.org/0000-0002-7506-0089)
- Huijuan Gan (ORCID: https://orcid.org/0000-0001-7845-0245)
- Fei Zhang (ORCID: https://orcid.org/0000-0002-1957-0543)
- Zhaoyang Yang (ORCID: https://orcid.org/0009-0004-3620-7115)
- Wanying Luo (ORCID: https://orcid.org/0009-0008-9144-6775)
- Kaiyue Huang
Institutions
- Fujian University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Drug Design Development and Therapy
- Published
- 2025-05-01
- DOI
- https://doi.org/10.2147/dddt.s514189
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00